

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of integrin activation (GO:0033623) | 8.15781719 |
| 2 | proline biosynthetic process (GO:0006561) | 5.75867554 |
| 3 | negative regulation of granulocyte differentiation (GO:0030853) | 5.57473379 |
| 4 | embryonic process involved in female pregnancy (GO:0060136) | 5.31670031 |
| 5 | apoptotic cell clearance (GO:0043277) | 5.16775115 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.85935621 |
| 7 | response to peptidoglycan (GO:0032494) | 4.65099118 |
| 8 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.49641366 |
| 9 | positive regulation of protein homooligomerization (GO:0032464) | 4.42772362 |
| 10 | embryonic placenta development (GO:0001892) | 4.37037556 |
| 11 | * negative regulation of interleukin-12 production (GO:0032695) | 4.30061611 |
| 12 | transcription from mitochondrial promoter (GO:0006390) | 4.25883345 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.21598209 |
| 14 | cellular response to zinc ion (GO:0071294) | 4.18793676 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.17483290 |
| 16 | glycosphingolipid catabolic process (GO:0046479) | 4.15214492 |
| 17 | proline metabolic process (GO:0006560) | 4.08834612 |
| 18 | low-density lipoprotein particle clearance (GO:0034383) | 4.07689998 |
| 19 | amino sugar catabolic process (GO:0046348) | 4.02138737 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.99605852 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.99605852 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.99605852 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.99605852 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.99605852 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.99605852 |
| 26 | regulation of apoptotic cell clearance (GO:2000425) | 3.97529768 |
| 27 | complement activation, alternative pathway (GO:0006957) | 3.96577894 |
| 28 | T-helper 1 type immune response (GO:0042088) | 3.83614208 |
| 29 | establishment of apical/basal cell polarity (GO:0035089) | 3.81448693 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 3.80167405 |
| 31 | N-acetylneuraminate metabolic process (GO:0006054) | 3.75063207 |
| 32 | positive regulation of mast cell activation (GO:0033005) | 3.74901677 |
| 33 | oligosaccharide catabolic process (GO:0009313) | 3.74086296 |
| 34 | glycolipid catabolic process (GO:0019377) | 3.72703543 |
| 35 | glial cell migration (GO:0008347) | 3.69093529 |
| 36 | negative regulation of stress fiber assembly (GO:0051497) | 3.65717109 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.64062877 |
| 38 | mannose metabolic process (GO:0006013) | 3.60838512 |
| 39 | regulation of protein homooligomerization (GO:0032462) | 3.58706048 |
| 40 | barbed-end actin filament capping (GO:0051016) | 3.56280989 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.53701144 |
| 42 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.51496816 |
| 43 | replication fork processing (GO:0031297) | 3.50479651 |
| 44 | detection of other organism (GO:0098543) | 3.50375600 |
| 45 | regulation of cholesterol storage (GO:0010885) | 3.46679528 |
| 46 | detection of external biotic stimulus (GO:0098581) | 3.46092411 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.44774500 |
| 48 | response to thyroid hormone (GO:0097066) | 3.42344287 |
| 49 | * regulation of mononuclear cell migration (GO:0071675) | 3.41830966 |
| 50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.41668090 |
| 51 | membrane invagination (GO:0010324) | 3.38006094 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 3.37330464 |
| 53 | endothelial cell chemotaxis (GO:0035767) | 3.35286107 |
| 54 | regulation of leukocyte degranulation (GO:0043300) | 3.33208214 |
| 55 | lipoxygenase pathway (GO:0019372) | 3.33085009 |
| 56 | regulation of antigen processing and presentation (GO:0002577) | 3.32265914 |
| 57 | regulation of T cell tolerance induction (GO:0002664) | 3.31777063 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.31009003 |
| 59 | cellular response to ATP (GO:0071318) | 3.30721701 |
| 60 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.30575693 |
| 61 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.29527589 |
| 62 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29310291 |
| 63 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.29298234 |
| 64 | ceramide catabolic process (GO:0046514) | 3.28435800 |
| 65 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23939272 |
| 66 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.20203883 |
| 67 | regulation of mast cell activation (GO:0033003) | 3.19460367 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19049438 |
| 69 | negative regulation of tumor necrosis factor production (GO:0032720) | 3.16899242 |
| 70 | basement membrane organization (GO:0071711) | 3.16634753 |
| 71 | protein localization to endosome (GO:0036010) | 3.16588342 |
| 72 | oxidative demethylation (GO:0070989) | 3.16143302 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 3.15946691 |
| 74 | detection of bacterium (GO:0016045) | 3.15664673 |
| 75 | apoptotic process involved in morphogenesis (GO:0060561) | 3.15033505 |
| 76 | establishment of monopolar cell polarity (GO:0061162) | 3.14111610 |
| 77 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.14111610 |
| 78 | regulation of podosome assembly (GO:0071801) | 3.11324513 |
| 79 | cellular extravasation (GO:0045123) | 3.10012019 |
| 80 | phagocytosis, engulfment (GO:0006911) | 3.09672894 |
| 81 | granulocyte activation (GO:0036230) | 3.08827090 |
| 82 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05826144 |
| 83 | myeloid dendritic cell differentiation (GO:0043011) | 3.05790550 |
| 84 | B cell mediated immunity (GO:0019724) | 3.05376059 |
| 85 | microglial cell activation (GO:0001774) | 3.05100894 |
| 86 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.04577807 |
| 87 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.03240741 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 3.02738833 |
| 89 | anatomical structure regression (GO:0060033) | 3.02731042 |
| 90 | negative regulation of interleukin-6 production (GO:0032715) | 3.01703152 |
| 91 | detection of biotic stimulus (GO:0009595) | 3.00312427 |
| 92 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.00170268 |
| 93 | protein heterotrimerization (GO:0070208) | 3.00008463 |
| 94 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.95918213 |
| 95 | adenosine receptor signaling pathway (GO:0001973) | 2.95661922 |
| 96 | regulation of tolerance induction (GO:0002643) | 2.95085256 |
| 97 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.93876188 |
| 98 | positive regulation of protein oligomerization (GO:0032461) | 2.92487422 |
| 99 | positive regulation of type 2 immune response (GO:0002830) | 2.90488311 |
| 100 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.90469879 |
| 101 | monocyte chemotaxis (GO:0002548) | 2.90296029 |
| 102 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.89996901 |
| 103 | macrophage differentiation (GO:0030225) | 2.88046996 |
| 104 | regulation of gamma-delta T cell activation (GO:0046643) | 2.87691780 |
| 105 | response to host immune response (GO:0052572) | 2.87636079 |
| 106 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.87636079 |
| 107 | regulation of monocyte chemotaxis (GO:0090025) | 2.87201432 |
| 108 | * regulation of macrophage chemotaxis (GO:0010758) | 2.87191182 |
| 109 | positive regulation of cholesterol efflux (GO:0010875) | 2.87042135 |
| 110 | response to laminar fluid shear stress (GO:0034616) | 2.86023239 |
| 111 | myeloid dendritic cell activation (GO:0001773) | 2.84919350 |
| 112 | negative regulation of cartilage development (GO:0061037) | 2.83727543 |
| 113 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82557841 |
| 114 | hypotonic response (GO:0006971) | 2.82276811 |
| 115 | keratan sulfate catabolic process (GO:0042340) | 2.81805634 |
| 116 | neutrophil activation (GO:0042119) | 2.80648097 |
| 117 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80126106 |
| 118 | face development (GO:0060324) | 2.79571116 |
| 119 | eosinophil chemotaxis (GO:0048245) | 2.78300108 |
| 120 | membrane lipid catabolic process (GO:0046466) | 2.77643199 |
| 121 | cellular response to interferon-gamma (GO:0071346) | 2.76823560 |
| 122 | lymphocyte chemotaxis (GO:0048247) | 2.76796055 |
| 123 | regulation of hypersensitivity (GO:0002883) | 2.76378800 |
| 124 | positive regulation of developmental pigmentation (GO:0048087) | 2.76150571 |
| 125 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.75525244 |
| 126 | dendritic cell differentiation (GO:0097028) | 2.74769411 |
| 127 | stress fiber assembly (GO:0043149) | 2.74590378 |
| 128 | respiratory burst (GO:0045730) | 2.74284798 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.70614035 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.70514903 |
| 131 | cellular response to type I interferon (GO:0071357) | 2.70514903 |
| 132 | positive regulation of receptor recycling (GO:0001921) | 2.69889194 |
| 133 | pinocytosis (GO:0006907) | 2.68288578 |
| 134 | response to type I interferon (GO:0034340) | 2.67176488 |
| 135 | negative regulation of interleukin-8 production (GO:0032717) | 2.66400386 |
| 136 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.66319619 |
| 137 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.66239977 |
| 138 | response to interferon-gamma (GO:0034341) | 2.66109034 |
| 139 | positive regulation of macrophage cytokine production (GO:0060907) | 2.65681730 |
| 140 | white fat cell differentiation (GO:0050872) | 2.65509885 |
| 141 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.65043286 |
| 142 | embryonic camera-type eye development (GO:0031076) | 2.60717973 |
| 143 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.59742769 |
| 144 | macrophage activation (GO:0042116) | 2.59170983 |
| 145 | embryonic eye morphogenesis (GO:0048048) | 2.57230907 |
| 146 | regulation of phagocytosis (GO:0050764) | 2.56351931 |
| 147 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.56301044 |
| 148 | negative regulation of cell killing (GO:0031342) | 2.56301044 |
| 149 | adaptation of signaling pathway (GO:0023058) | 2.53703588 |
| 150 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.52400884 |
| 151 | germinal center formation (GO:0002467) | 2.51885532 |
| 152 | mitochondrial DNA metabolic process (GO:0032042) | 2.51551973 |
| 153 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.48611411 |
| 154 | fatty acid transmembrane transport (GO:1902001) | 2.46204351 |
| 155 | positive regulation of mast cell degranulation (GO:0043306) | 2.45773280 |
| 156 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.45773280 |
| 157 | positive regulation of sterol transport (GO:0032373) | 2.45343676 |
| 158 | positive regulation of cholesterol transport (GO:0032376) | 2.45343676 |
| 159 | cellular response to lithium ion (GO:0071285) | 2.45318725 |
| 160 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.43271181 |
| 161 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.43169538 |
| 162 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.42492698 |
| 163 | positive regulation of antigen processing and presentation (GO:0002579) | 2.41107940 |
| 164 | brown fat cell differentiation (GO:0050873) | 2.40975386 |
| 165 | regulation of response to reactive oxygen species (GO:1901031) | 2.40242992 |
| 166 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.39133178 |
| 167 | negative regulation of cell cycle arrest (GO:0071157) | 2.38286198 |
| 168 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.38056464 |
| 169 | positive regulation of leukocyte degranulation (GO:0043302) | 2.36743232 |
| 170 | protein targeting to vacuole (GO:0006623) | 2.36614177 |
| 171 | protein targeting to lysosome (GO:0006622) | 2.36614177 |
| 172 | establishment of protein localization to vacuole (GO:0072666) | 2.36614177 |
| 173 | regulation of protein oligomerization (GO:0032459) | 2.35916333 |
| 174 | nodal signaling pathway (GO:0038092) | 2.35675681 |
| 175 | leukocyte cell-cell adhesion (GO:0007159) | 2.35638800 |
| 176 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.35511355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.22021703 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.08334188 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.07102112 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.83540448 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.81166966 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.78889403 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.65442616 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.56080685 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53081222 |
| 10 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.52531587 |
| 11 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.52531587 |
| 12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.52531587 |
| 13 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.46310473 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.38952988 |
| 15 | * VDR_24787735_ChIP-Seq_THP-1_Human | 2.24019404 |
| 16 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22490445 |
| 17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.21126593 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.19944282 |
| 19 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.17383274 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.16647943 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.16314689 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13636941 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.12232796 |
| 24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11467237 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.03515622 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.02629582 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01450885 |
| 28 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.01325141 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85540031 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84841380 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80011731 |
| 32 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.78864938 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73344815 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67178618 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.66597509 |
| 36 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.64421359 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62794360 |
| 38 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.61557107 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60025241 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58926463 |
| 41 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58579247 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58509707 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55865133 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55598753 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54586357 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52525498 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51416507 |
| 48 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.49966467 |
| 49 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.49345497 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49065186 |
| 51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.48997396 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48248582 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47822085 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46532206 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46518859 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44985330 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43908355 |
| 58 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.43696657 |
| 59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43500648 |
| 60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.42146366 |
| 61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41477458 |
| 62 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.40950478 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39277655 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38452095 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37417522 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 1.33041718 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32273439 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31696838 |
| 69 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31633240 |
| 70 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30990596 |
| 71 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29931793 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29611550 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29357216 |
| 74 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.29246378 |
| 75 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.28495715 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28470359 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28201967 |
| 78 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27804632 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.27525799 |
| 80 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.27047394 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25830512 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 1.25412083 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24152800 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24034223 |
| 85 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23574855 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23139491 |
| 87 | MYB_26560356_Chip-Seq_TH2_Human | 1.22528306 |
| 88 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.22381693 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22209133 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22183975 |
| 91 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.22131249 |
| 92 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.22078435 |
| 93 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21670567 |
| 94 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21143341 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20700864 |
| 96 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.20499569 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19664229 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18792632 |
| 99 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17982949 |
| 100 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17584012 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16619419 |
| 102 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15327747 |
| 103 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14916320 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14721432 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.14345349 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12651085 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12615277 |
| 108 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.12336919 |
| 109 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11744435 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10546496 |
| 111 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.09730220 |
| 112 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09669085 |
| 113 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09475145 |
| 114 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08723584 |
| 115 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08640707 |
| 116 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.07698719 |
| 117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06343655 |
| 118 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05650928 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05432773 |
| 120 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05172605 |
| 121 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05121397 |
| 122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04827177 |
| 123 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03157670 |
| 124 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00898030 |
| 125 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00685906 |
| 126 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00519583 |
| 127 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00047188 |
| 128 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99981889 |
| 129 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.99428861 |
| 130 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98956162 |
| 131 | MYB_26560356_Chip-Seq_TH1_Human | 0.98480411 |
| 132 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98211176 |
| 133 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97562879 |
| 134 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96965238 |
| 135 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95687143 |
| 136 | MAF_26560356_Chip-Seq_TH2_Human | 0.94769739 |
| 137 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94584640 |
| 138 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93640542 |
| 139 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.91228127 |
| 140 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91172833 |
| 141 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90196883 |
| 142 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88605488 |
| 143 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87224768 |
| 144 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86058224 |
| 145 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85574942 |
| 146 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81510288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 3.66715935 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.64123109 |
| 3 | MP0009278_abnormal_bone_marrow | 3.60567441 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.46970781 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.77654366 |
| 6 | MP0005171_absent_coat_pigmentation | 2.77507235 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.51546515 |
| 8 | MP0006082_CNS_inflammation | 2.46281062 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.37226704 |
| 10 | MP0000604_amyloidosis | 2.34155617 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.23016955 |
| 12 | MP0003828_pulmonary_edema | 2.19916948 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.18652230 |
| 14 | MP0003724_increased_susceptibility_to | 2.18528156 |
| 15 | MP0004130_abnormal_muscle_cell | 2.08684995 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.07842002 |
| 17 | MP0005666_abnormal_adipose_tissue | 2.05981131 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 1.97179412 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 1.95474846 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.95474846 |
| 21 | MP0000343_altered_response_to | 1.91033811 |
| 22 | MP0003075_altered_response_to | 1.90914111 |
| 23 | MP0003436_decreased_susceptibility_to | 1.88002072 |
| 24 | MP0003045_fibrosis | 1.84719654 |
| 25 | MP0009764_decreased_sensitivity_to | 1.78034331 |
| 26 | MP0002009_preneoplasia | 1.71270611 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.70938928 |
| 28 | MP0009115_abnormal_fat_cell | 1.69518855 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.68016718 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.63729688 |
| 31 | MP0005275_abnormal_skin_tensile | 1.63680123 |
| 32 | MP0008057_abnormal_DNA_replication | 1.62240525 |
| 33 | MP0005310_abnormal_salivary_gland | 1.61523805 |
| 34 | MP0008469_abnormal_protein_level | 1.60656713 |
| 35 | MP0008260_abnormal_autophagy | 1.58927220 |
| 36 | MP0001853_heart_inflammation | 1.57204597 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.53109929 |
| 38 | * MP0002419_abnormal_innate_immunity | 1.49020655 |
| 39 | MP0005451_abnormal_body_composition | 1.48773721 |
| 40 | MP0000858_altered_metastatic_potential | 1.45792692 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.42771969 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.42650715 |
| 43 | MP0002006_tumorigenesis | 1.42581303 |
| 44 | MP0003279_aneurysm | 1.39098773 |
| 45 | MP0001790_abnormal_immune_system | 1.34354528 |
| 46 | MP0005387_immune_system_phenotype | 1.34354528 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.33596165 |
| 48 | MP0003448_altered_tumor_morphology | 1.33297899 |
| 49 | MP0006054_spinal_hemorrhage | 1.32839530 |
| 50 | MP0005023_abnormal_wound_healing | 1.32131341 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.31777853 |
| 52 | MP0005025_abnormal_response_to | 1.31514471 |
| 53 | MP0002971_abnormal_brown_adipose | 1.31408547 |
| 54 | MP0003303_peritoneal_inflammation | 1.28997506 |
| 55 | MP0005166_decreased_susceptibility_to | 1.28740126 |
| 56 | MP0000371_diluted_coat_color | 1.27239482 |
| 57 | MP0000920_abnormal_myelination | 1.25456268 |
| 58 | * MP0000716_abnormal_immune_system | 1.23295568 |
| 59 | MP0004233_abnormal_muscle_weight | 1.21956943 |
| 60 | MP0009840_abnormal_foam_cell | 1.21664566 |
| 61 | MP0004883_abnormal_blood_vessel | 1.19941233 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.19635808 |
| 63 | MP0002060_abnormal_skin_morphology | 1.19419466 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.17922390 |
| 65 | * MP0002405_respiratory_system_inflammati | 1.17824929 |
| 66 | MP0005390_skeleton_phenotype | 1.12460384 |
| 67 | MP0003329_amyloid_beta_deposits | 1.11497084 |
| 68 | MP0000767_abnormal_smooth_muscle | 1.10679194 |
| 69 | MP0005000_abnormal_immune_tolerance | 1.09699932 |
| 70 | MP0003690_abnormal_glial_cell | 1.09552302 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.08724106 |
| 72 | MP0004272_abnormal_basement_membrane | 1.07652924 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 1.07290376 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.06627194 |
| 75 | MP0002254_reproductive_system_inflammat | 1.05587367 |
| 76 | MP0010030_abnormal_orbit_morphology | 1.05436272 |
| 77 | * MP0002452_abnormal_antigen_presenting | 1.04760848 |
| 78 | MP0002168_other_aberrant_phenotype | 1.04646109 |
| 79 | MP0008995_early_reproductive_senescence | 1.03805738 |
| 80 | MP0000249_abnormal_blood_vessel | 1.02972241 |
| 81 | MP0001800_abnormal_humoral_immune | 1.00852624 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.99926715 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.98700998 |
| 84 | MP0001915_intracranial_hemorrhage | 0.98645228 |
| 85 | MP0002282_abnormal_trachea_morphology | 0.97471073 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.97426454 |
| 87 | MP0002398_abnormal_bone_marrow | 0.96320017 |
| 88 | MP0001542_abnormal_bone_strength | 0.96101261 |
| 89 | MP0005334_abnormal_fat_pad | 0.94661272 |
| 90 | MP0005365_abnormal_bile_salt | 0.93448485 |
| 91 | MP0010630_abnormal_cardiac_muscle | 0.93382039 |
| 92 | * MP0002429_abnormal_blood_cell | 0.92747192 |
| 93 | MP0003795_abnormal_bone_structure | 0.92366068 |
| 94 | MP0009763_increased_sensitivity_to | 0.91039127 |
| 95 | MP0010368_abnormal_lymphatic_system | 0.89815939 |
| 96 | MP0002933_joint_inflammation | 0.88633711 |
| 97 | MP0005508_abnormal_skeleton_morphology | 0.87955291 |
| 98 | MP0004510_myositis | 0.86395717 |
| 99 | MP0001958_emphysema | 0.85600082 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.85283758 |
| 101 | MP0002723_abnormal_immune_serum | 0.84343130 |
| 102 | MP0000465_gastrointestinal_hemorrhage | 0.83642567 |
| 103 | MP0002970_abnormal_white_adipose | 0.82181486 |
| 104 | * MP0001845_abnormal_inflammatory_respons | 0.82082048 |
| 105 | MP0000689_abnormal_spleen_morphology | 0.82052938 |
| 106 | MP0002086_abnormal_extraembryonic_tissu | 0.81965226 |
| 107 | MP0002249_abnormal_larynx_morphology | 0.81085295 |
| 108 | MP0002277_abnormal_respiratory_mucosa | 0.80214696 |
| 109 | * MP0001819_abnormal_immune_cell | 0.80211918 |
| 110 | MP0005164_abnormal_response_to | 0.79995475 |
| 111 | * MP0002420_abnormal_adaptive_immunity | 0.79644010 |
| 112 | MP0002722_abnormal_immune_system | 0.79255775 |
| 113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77729886 |
| 114 | MP0002396_abnormal_hematopoietic_system | 0.76955215 |
| 115 | MP0001851_eye_inflammation | 0.76383305 |
| 116 | MP0005595_abnormal_vascular_smooth | 0.74730388 |
| 117 | MP0000490_abnormal_crypts_of | 0.73418289 |
| 118 | MP0001614_abnormal_blood_vessel | 0.73347919 |
| 119 | MP0005671_abnormal_response_to | 0.73344495 |
| 120 | MP0008004_abnormal_stomach_pH | 0.73114128 |
| 121 | * MP0000685_abnormal_immune_system | 0.72234301 |
| 122 | MP0000609_abnormal_liver_physiology | 0.71640021 |
| 123 | MP0002108_abnormal_muscle_morphology | 0.71571073 |
| 124 | MP0001663_abnormal_digestive_system | 0.71251554 |
| 125 | MP0002877_abnormal_melanocyte_morpholog | 0.71060740 |
| 126 | MP0005165_increased_susceptibility_to | 0.69925827 |
| 127 | MP0010155_abnormal_intestine_physiology | 0.69743372 |
| 128 | MP0003091_abnormal_cell_migration | 0.69232620 |
| 129 | MP0002295_abnormal_pulmonary_circulatio | 0.69209441 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.67634962 |
| 131 | MP0002925_abnormal_cardiovascular_devel | 0.67459759 |
| 132 | MP0004947_skin_inflammation | 0.67328133 |
| 133 | MP0003634_abnormal_glial_cell | 0.67044310 |
| 134 | MP0002090_abnormal_vision | 0.66571378 |
| 135 | MP0009785_altered_susceptibility_to | 0.66134034 |
| 136 | MP0010329_abnormal_lipoprotein_level | 0.66070163 |
| 137 | MP0005257_abnormal_intraocular_pressure | 0.65615520 |
| 138 | MP0008874_decreased_physiological_sensi | 0.62549778 |
| 139 | MP0010307_abnormal_tumor_latency | 0.60916175 |
| 140 | MP0002896_abnormal_bone_mineralization | 0.58908585 |
| 141 | MP0001849_ear_inflammation | 0.57697703 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.56805758 |
| 143 | MP0003763_abnormal_thymus_physiology | 0.56521829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.86151474 |
| 2 | Cerebral aneurysm (HP:0004944) | 5.26368132 |
| 3 | Complement deficiency (HP:0004431) | 5.24706188 |
| 4 | Glomerulonephritis (HP:0000099) | 5.18063011 |
| 5 | Pustule (HP:0200039) | 4.81551534 |
| 6 | Dysostosis multiplex (HP:0000943) | 4.80020723 |
| 7 | Abnormality of complement system (HP:0005339) | 4.77706918 |
| 8 | Mucopolysacchariduria (HP:0008155) | 4.46396422 |
| 9 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.46396422 |
| 10 | Disinhibition (HP:0000734) | 4.35613791 |
| 11 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.17483286 |
| 12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.17483286 |
| 13 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.17483286 |
| 14 | Asymmetric septal hypertrophy (HP:0001670) | 3.95542166 |
| 15 | Mutism (HP:0002300) | 3.93173314 |
| 16 | Nephritis (HP:0000123) | 3.82037590 |
| 17 | Alopecia of scalp (HP:0002293) | 3.58389248 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.42880341 |
| 19 | Joint stiffness (HP:0001387) | 3.38245430 |
| 20 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.30917221 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.26615093 |
| 22 | Turricephaly (HP:0000262) | 3.24877635 |
| 23 | Intestinal fistula (HP:0100819) | 3.21193705 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.20830105 |
| 25 | Rectal fistula (HP:0100590) | 3.20307507 |
| 26 | Rectovaginal fistula (HP:0000143) | 3.20307507 |
| 27 | Neurofibrillary tangles (HP:0002185) | 3.15389163 |
| 28 | Ulnar bowing (HP:0003031) | 3.08705400 |
| 29 | Vaginal fistula (HP:0004320) | 3.08530253 |
| 30 | Eczematoid dermatitis (HP:0000976) | 3.04143511 |
| 31 | Increased IgM level (HP:0003496) | 3.03292638 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.01926693 |
| 33 | Purpura (HP:0000979) | 2.87712183 |
| 34 | Myocardial infarction (HP:0001658) | 2.86459681 |
| 35 | Myositis (HP:0100614) | 2.85782122 |
| 36 | Orchitis (HP:0100796) | 2.85635505 |
| 37 | Annular pancreas (HP:0001734) | 2.85517215 |
| 38 | Polycythemia (HP:0001901) | 2.83091924 |
| 39 | Recurrent skin infections (HP:0001581) | 2.75924958 |
| 40 | Nuclear cataract (HP:0100018) | 2.71694120 |
| 41 | Spondylolisthesis (HP:0003302) | 2.71320030 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 2.70854556 |
| 43 | Obstructive lung disease (HP:0006536) | 2.70798714 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70798714 |
| 45 | Upper motor neuron abnormality (HP:0002127) | 2.70239198 |
| 46 | Agnosia (HP:0010524) | 2.66174801 |
| 47 | Shallow orbits (HP:0000586) | 2.65778538 |
| 48 | Rib fusion (HP:0000902) | 2.63700365 |
| 49 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.56721885 |
| 50 | Hematochezia (HP:0002573) | 2.54576188 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.54273786 |
| 52 | Optic neuritis (HP:0100653) | 2.54273786 |
| 53 | Neuronal loss in central nervous system (HP:0002529) | 2.53457807 |
| 54 | Coarse hair (HP:0002208) | 2.53040124 |
| 55 | Colitis (HP:0002583) | 2.50211864 |
| 56 | Increased serum ferritin (HP:0003281) | 2.44027636 |
| 57 | Amyloidosis (HP:0011034) | 2.43016640 |
| 58 | Albinism (HP:0001022) | 2.40924951 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.39531064 |
| 60 | Orthostatic hypotension (HP:0001278) | 2.39269055 |
| 61 | Inappropriate behavior (HP:0000719) | 2.38853531 |
| 62 | Increased cerebral lipofuscin (HP:0011813) | 2.38342134 |
| 63 | Vacuolated lymphocytes (HP:0001922) | 2.38291993 |
| 64 | Apathy (HP:0000741) | 2.37904282 |
| 65 | Growth hormone excess (HP:0000845) | 2.36168522 |
| 66 | Diminished motivation (HP:0000745) | 2.34836802 |
| 67 | Stomatitis (HP:0010280) | 2.31766252 |
| 68 | Retinal atrophy (HP:0001105) | 2.31291472 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.30718109 |
| 70 | Coronal craniosynostosis (HP:0004440) | 2.30344705 |
| 71 | Short humerus (HP:0005792) | 2.27297800 |
| 72 | Hemoptysis (HP:0002105) | 2.27189895 |
| 73 | Arterial tortuosity (HP:0005116) | 2.25143800 |
| 74 | Cerebral inclusion bodies (HP:0100314) | 2.24654027 |
| 75 | Premature skin wrinkling (HP:0100678) | 2.24253970 |
| 76 | Vertebral hypoplasia (HP:0008417) | 2.20985240 |
| 77 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.20985240 |
| 78 | Malnutrition (HP:0004395) | 2.20011581 |
| 79 | Progressive neurologic deterioration (HP:0002344) | 2.19727438 |
| 80 | Conjunctival telangiectasia (HP:0000524) | 2.19102985 |
| 81 | Pathologic fracture (HP:0002756) | 2.18240189 |
| 82 | Hepatosplenomegaly (HP:0001433) | 2.16134007 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.14659589 |
| 84 | Meningitis (HP:0001287) | 2.13259686 |
| 85 | Cervical subluxation (HP:0003308) | 2.13023916 |
| 86 | Axonal loss (HP:0003447) | 2.12942278 |
| 87 | Metaphyseal irregularity (HP:0003025) | 2.12486293 |
| 88 | Concave nail (HP:0001598) | 2.12204105 |
| 89 | Petechiae (HP:0000967) | 2.12170370 |
| 90 | Large for gestational age (HP:0001520) | 2.10881532 |
| 91 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10090528 |
| 92 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10090528 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10070047 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10070047 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10070047 |
| 96 | Personality changes (HP:0000751) | 2.09028241 |
| 97 | Vascular tortuosity (HP:0004948) | 2.08647150 |
| 98 | Urethral obstruction (HP:0000796) | 2.07971286 |
| 99 | Bulbar palsy (HP:0001283) | 2.05368406 |
| 100 | Aortic aneurysm (HP:0004942) | 2.05361414 |
| 101 | Increased CSF protein (HP:0002922) | 2.04947948 |
| 102 | Male infertility (HP:0003251) | 2.04698776 |
| 103 | Prolonged bleeding time (HP:0003010) | 2.02694747 |
| 104 | Broad metatarsal (HP:0001783) | 2.02570149 |
| 105 | Urticaria (HP:0001025) | 2.02467180 |
| 106 | Dementia (HP:0000726) | 2.02352860 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.01822433 |
| 108 | Bowed forearm bones (HP:0003956) | 2.01806258 |
| 109 | Bowing of the arm (HP:0006488) | 2.01806258 |
| 110 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.01300565 |
| 111 | Premature loss of primary teeth (HP:0006323) | 2.01169516 |
| 112 | Basal ganglia calcification (HP:0002135) | 2.01116752 |
| 113 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.00181187 |
| 114 | Vertebral compression fractures (HP:0002953) | 2.00137055 |
| 115 | Vasculitis (HP:0002633) | 1.99877908 |
| 116 | Intestinal atresia (HP:0011100) | 1.99465539 |
| 117 | T lymphocytopenia (HP:0005403) | 1.98660598 |
| 118 | Cellulitis (HP:0100658) | 1.97879904 |
| 119 | Recurrent viral infections (HP:0004429) | 1.96511545 |
| 120 | Polyneuropathy (HP:0001271) | 1.95878818 |
| 121 | Abnormal hemoglobin (HP:0011902) | 1.95463070 |
| 122 | Progressive visual loss (HP:0000529) | 1.94916887 |
| 123 | Acanthosis nigricans (HP:0000956) | 1.94668848 |
| 124 | Aneurysm (HP:0002617) | 1.94111708 |
| 125 | Global brain atrophy (HP:0002283) | 1.93828209 |
| 126 | Abnormality of male internal genitalia (HP:0000022) | 1.92383062 |
| 127 | Bone pain (HP:0002653) | 1.91098938 |
| 128 | Loss of speech (HP:0002371) | 1.90907220 |
| 129 | Thoracic kyphosis (HP:0002942) | 1.90854289 |
| 130 | Ovoid vertebral bodies (HP:0003300) | 1.90563465 |
| 131 | Oligomenorrhea (HP:0000876) | 1.89671595 |
| 132 | Gingivitis (HP:0000230) | 1.87895232 |
| 133 | Peripheral demyelination (HP:0011096) | 1.87780576 |
| 134 | Aortic dissection (HP:0002647) | 1.87407073 |
| 135 | Increased connective tissue (HP:0009025) | 1.87114536 |
| 136 | Abnormality of macrophages (HP:0004311) | 1.86341319 |
| 137 | Spinal muscular atrophy (HP:0007269) | 1.85868379 |
| 138 | Restrictive lung disease (HP:0002091) | 1.85349707 |
| 139 | Autoimmune thrombocytopenia (HP:0001973) | 1.84881008 |
| 140 | Acrocyanosis (HP:0001063) | 1.84488493 |
| 141 | Striae distensae (HP:0001065) | 1.82585062 |
| 142 | Facial hemangioma (HP:0000329) | 1.82375948 |
| 143 | Abnormality of T cell number (HP:0011839) | 1.81442301 |
| 144 | Cardiomegaly (HP:0001640) | 1.81290873 |
| 145 | Abnormality of the periventricular white matter (HP:0002518) | 1.80410674 |
| 146 | Prostate neoplasm (HP:0100787) | 1.79723735 |
| 147 | Recurrent fungal infections (HP:0002841) | 1.79154040 |
| 148 | Generalized amyotrophy (HP:0003700) | 1.79051216 |
| 149 | Muscle fibrillation (HP:0010546) | 1.79030717 |
| 150 | Mucosal telangiectasiae (HP:0100579) | 1.78042682 |
| 151 | Gastrointestinal infarctions (HP:0005244) | 1.77889106 |
| 152 | Keratoconjunctivitis sicca (HP:0001097) | 1.77739379 |
| 153 | Menorrhagia (HP:0000132) | 1.77664418 |
| 154 | Epistaxis (HP:0000421) | 1.77407836 |
| 155 | Inflammation of the large intestine (HP:0002037) | 1.76834249 |
| 156 | Clumsiness (HP:0002312) | 1.75884538 |
| 157 | IgA deficiency (HP:0002720) | 1.74699371 |
| 158 | Hypotrichosis (HP:0001006) | 1.74322072 |
| 159 | Nasal polyposis (HP:0100582) | 1.71994443 |
| 160 | Hypochromic microcytic anemia (HP:0004840) | 1.70756905 |
| 161 | Cheilitis (HP:0100825) | 1.68485915 |
| 162 | Tongue fasciculations (HP:0001308) | 1.67123982 |
| 163 | Hemorrhage of the eye (HP:0011885) | 1.66568859 |
| 164 | Poikiloderma (HP:0001029) | 1.66002142 |
| 165 | Deformed sella turcica (HP:0002681) | 1.65471820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.38194368 |
| 2 | ICK | 4.33069438 |
| 3 | DDR2 | 3.72477037 |
| 4 | MAP3K6 | 3.62822917 |
| 5 | TGFBR2 | 3.07443201 |
| 6 | CAMK1D | 2.89057113 |
| 7 | CSK | 2.64955990 |
| 8 | MATK | 2.55096583 |
| 9 | FGR | 2.52599610 |
| 10 | MAP3K11 | 2.41948822 |
| 11 | BMX | 2.40022582 |
| 12 | NME2 | 2.20332768 |
| 13 | TRIB3 | 2.18266557 |
| 14 | MST1R | 2.01348189 |
| 15 | PINK1 | 1.99903882 |
| 16 | CAMK1G | 1.99508036 |
| 17 | PDGFRA | 1.93302717 |
| 18 | RIPK1 | 1.83190494 |
| 19 | TYRO3 | 1.73310570 |
| 20 | MAP3K13 | 1.70262806 |
| 21 | ERN1 | 1.68414790 |
| 22 | PRKD2 | 1.62802077 |
| 23 | ACVR1B | 1.60935692 |
| 24 | BLK | 1.59574898 |
| 25 | TRPM7 | 1.59099825 |
| 26 | CAMKK2 | 1.56440179 |
| 27 | YES1 | 1.51156970 |
| 28 | IKBKE | 1.47264406 |
| 29 | MAP3K3 | 1.44291566 |
| 30 | DAPK1 | 1.43262083 |
| 31 | FES | 1.38191461 |
| 32 | CDK6 | 1.35878260 |
| 33 | TAOK2 | 1.34789582 |
| 34 | SYK | 1.33847199 |
| 35 | TYK2 | 1.32281045 |
| 36 | TAOK1 | 1.21106742 |
| 37 | RPS6KC1 | 1.17381054 |
| 38 | RPS6KL1 | 1.17381054 |
| 39 | PIM2 | 1.16662414 |
| 40 | MAP3K10 | 1.13443309 |
| 41 | MAP4K1 | 1.12942425 |
| 42 | DYRK1B | 1.11993258 |
| 43 | GSK3A | 1.10400923 |
| 44 | ABL2 | 1.10038733 |
| 45 | SIK1 | 1.09577149 |
| 46 | RPS6KA6 | 1.08948267 |
| 47 | PIM1 | 1.08181167 |
| 48 | MOS | 1.01443605 |
| 49 | NEK9 | 1.00492918 |
| 50 | TTN | 0.99824618 |
| 51 | TIE1 | 0.95531083 |
| 52 | MAP3K1 | 0.94656158 |
| 53 | CSF1R | 0.94186174 |
| 54 | TGFBR1 | 0.93318439 |
| 55 | EPHB1 | 0.92223264 |
| 56 | CDK12 | 0.91343674 |
| 57 | GRK7 | 0.91073889 |
| 58 | TESK2 | 0.90508635 |
| 59 | BTK | 0.89951116 |
| 60 | PRKAA2 | 0.85986234 |
| 61 | STK10 | 0.84381811 |
| 62 | PAK4 | 0.81665343 |
| 63 | TESK1 | 0.81384798 |
| 64 | PRPF4B | 0.81143601 |
| 65 | MET | 0.81121827 |
| 66 | ADRBK2 | 0.80434817 |
| 67 | MAPK11 | 0.80072646 |
| 68 | JAK1 | 0.79937033 |
| 69 | CDK7 | 0.79074820 |
| 70 | FGFR4 | 0.77595642 |
| 71 | EPHA2 | 0.74514959 |
| 72 | TBK1 | 0.71876246 |
| 73 | RIPK4 | 0.70814035 |
| 74 | IRAK3 | 0.70294931 |
| 75 | ZAP70 | 0.70233889 |
| 76 | DMPK | 0.69645342 |
| 77 | PDGFRB | 0.69588796 |
| 78 | PDPK1 | 0.69504313 |
| 79 | LATS2 | 0.69264605 |
| 80 | UHMK1 | 0.67681524 |
| 81 | PHKG2 | 0.67420649 |
| 82 | PHKG1 | 0.67420649 |
| 83 | LATS1 | 0.66927831 |
| 84 | MTOR | 0.66614066 |
| 85 | EGFR | 0.65367945 |
| 86 | LYN | 0.65031601 |
| 87 | IKBKB | 0.64811777 |
| 88 | STK3 | 0.64629584 |
| 89 | BMPR2 | 0.63486627 |
| 90 | HCK | 0.62200852 |
| 91 | CDC42BPA | 0.61781022 |
| 92 | PRKAA1 | 0.60721083 |
| 93 | IRAK4 | 0.60098852 |
| 94 | JAK2 | 0.59919894 |
| 95 | EPHB2 | 0.59496434 |
| 96 | MAPK7 | 0.58676143 |
| 97 | LCK | 0.57612285 |
| 98 | SIK3 | 0.57140654 |
| 99 | MAP2K3 | 0.56566504 |
| 100 | PIK3CG | 0.55965214 |
| 101 | SIK2 | 0.55688880 |
| 102 | PDK1 | 0.53994036 |
| 103 | RPS6KA2 | 0.53719608 |
| 104 | MARK2 | 0.52423975 |
| 105 | MAP3K5 | 0.50440858 |
| 106 | AKT3 | 0.49426584 |
| 107 | CAMKK1 | 0.47095609 |
| 108 | DAPK2 | 0.46243663 |
| 109 | KIT | 0.46238236 |
| 110 | KSR2 | 0.45947428 |
| 111 | RPS6KA1 | 0.45603342 |
| 112 | ITK | 0.45161174 |
| 113 | KSR1 | 0.44826695 |
| 114 | PRKG2 | 0.44517850 |
| 115 | PRKD1 | 0.42840761 |
| 116 | EPHA3 | 0.42495565 |
| 117 | IRAK1 | 0.42216126 |
| 118 | MAP2K6 | 0.41563711 |
| 119 | INSR | 0.41480779 |
| 120 | MARK3 | 0.41353697 |
| 121 | STK38 | 0.40697351 |
| 122 | ARAF | 0.40251898 |
| 123 | TAOK3 | 0.40235715 |
| 124 | CHUK | 0.40110008 |
| 125 | PDK2 | 0.40003559 |
| 126 | MAPK4 | 0.38201198 |
| 127 | FYN | 0.38135810 |
| 128 | FGFR3 | 0.38001214 |
| 129 | IRAK2 | 0.37925865 |
| 130 | MAPKAPK2 | 0.37574153 |
| 131 | JAK3 | 0.36085001 |
| 132 | HIPK2 | 0.35491991 |
| 133 | TXK | 0.34030197 |
| 134 | CDK4 | 0.32436669 |
| 135 | PRKCH | 0.32313737 |
| 136 | MAPK3 | 0.31199713 |
| 137 | ABL1 | 0.30687884 |
| 138 | MAPK1 | 0.29573578 |
| 139 | MAPK12 | 0.28988467 |
| 140 | MAP3K14 | 0.28349465 |
| 141 | PAK2 | 0.28220867 |
| 142 | TNK2 | 0.27670549 |
| 143 | PRKCD | 0.26203776 |
| 144 | MAPKAPK3 | 0.26166483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.39076562 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.37370462 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.50299624 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.82373415 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.62150857 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.42556111 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.31547183 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.13574734 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.01689810 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 1.89087014 |
| 11 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.88654634 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.85668234 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85331235 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78607150 |
| 15 | Adherens junction_Homo sapiens_hsa04520 | 1.76136395 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.71383973 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53577528 |
| 18 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.50701052 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.47772068 |
| 20 | Prion diseases_Homo sapiens_hsa05020 | 1.45830022 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38324737 |
| 22 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.36485117 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34016806 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32972392 |
| 25 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.26580050 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24804835 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24212698 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.21019884 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19787253 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17185321 |
| 31 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.13344088 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13120364 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12915011 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.12165335 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10719612 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10443755 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.09589461 |
| 38 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.07738792 |
| 39 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06669678 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04522121 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04249418 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04017697 |
| 43 | Focal adhesion_Homo sapiens_hsa04510 | 1.03991906 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02976921 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01788239 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01043143 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99772099 |
| 48 | Measles_Homo sapiens_hsa05162 | 0.99315659 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99005109 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 0.97098717 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.96510518 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.91754655 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.90130806 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89635195 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88413885 |
| 56 | Mineral absorption_Homo sapiens_hsa04978 | 0.87289744 |
| 57 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.85411182 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83535820 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82901656 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82745316 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82673252 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.81607623 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81434078 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81395195 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81001820 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.80994018 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79173721 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78636624 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78254719 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77903004 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76677808 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76199095 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73121157 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71798636 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71191223 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70996222 |
| 77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70005272 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69987012 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.69436652 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.68413012 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67688808 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66767109 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66460752 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66184985 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65810270 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64989648 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64779307 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.64153631 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62943452 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.62259594 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62255136 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.62115782 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.62047061 |
| 94 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62022586 |
| 95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60757882 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60463144 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59544196 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.58662689 |
| 99 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58170565 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57074160 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56914419 |
| 102 | Mismatch repair_Homo sapiens_hsa03430 | 0.56404889 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56188326 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55256856 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53266865 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52980966 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50236344 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50036304 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50029530 |
| 110 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49912559 |
| 111 | Influenza A_Homo sapiens_hsa05164 | 0.49770677 |
| 112 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48655827 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48464304 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48392320 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47787523 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45954559 |
| 117 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44486129 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44230001 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44007149 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41873726 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41625130 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40750080 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40532526 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39625438 |
| 125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39396350 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39292117 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39153926 |
| 128 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38443108 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37652261 |
| 130 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.37264620 |
| 131 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33715782 |
| 132 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33310277 |
| 133 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32837710 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27374060 |
| 135 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.20980533 |
| 136 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.18048700 |
| 137 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.16967230 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16456153 |

